Fact CheckerSign in

NCT07661979Not yet recruitingPhase 4

Opzelura Experience Study

Source: ClinicalTrials.gov · Last updated 4 Sept 2026

Brief summary (registry, in English)

Atopic dermatitis is a common multifactorial skin disease. Topicals are the mainstay of treatment, but adherence to topicals is often abysmal, possibly worsened by the complexity of recommended treatment algorithms. Giving patients a simple, one drug approach may be advantageous.

Status (registry)
Not yet recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
First submitted
17 Jun 2026
Start date
1 Dec 2026
Primary completion date
31 Aug 2027
Lead sponsor
Wake Forest University Health Sciences
NCT number
NCT07661979

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 50
  • From 1 Dec 2026 to the primary completion date, 31 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who are prescribed changing systemic medications or treatments (phototherapy, biologics) for atopic dermatitis
  • Patients who would require use of other topical medications for other diagnoses (tretinoin, clindamycin)

Other illness

  • Patients with areas of skin with active infection

Other

  • Patients without a current diagnosis of atopic dermatitis
  • Patients who are pregnant

Who the study is looking for

  • Patients ≥2 years of age
  • Patients with a current diagnosis of atopic dermatitis that is mild-to-moderate in severity and in ≥2 body areas
  • Patients with up to 20% total body surface area involvement
  • Women of childbearing age taking/using a contraceptive

Age in the registry: 2 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Wake Forest University Health Sciences
Coordinator of this site? Confirm its status
Winston-SalemUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.